
    
        <!DOCTYPE html>
        <html lang="hu-HU" data-website-id="1" data-oe-company-name="HBS Medical">
            
<!-- Mirrored from hbs.hu/slides/slide/diagnostic-criteria-classification-and-nomenclature-for-59 by HTTrack Website Copier/3.x [XR&CO'2014], Mon, 31 May 2021 15:58:55 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
                <meta charset="utf-8"/>
                <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"/>
                <meta name="viewport" content="width=device-width, initial-scale=1, user-scalable=no"/>

                <title>Diagnostic Criteria, Classification, and Nomenclature for | HBS</title>
                <link type="image/x-icon" rel="shortcut icon" href="../../web/image/website/1/favicon/index.html"/>

                <script type="text/javascript">
                    var odoo = {
                        csrf_token: "f2e9a41588799d043a772b21ddc3189150ea199fo",
                    };
                </script>

                
            <meta name="generator" content="Odoo"/>

            
            
            
            
            
            
                
                
                
                    
                        <meta property="og:type" content="website"/>
                    
                        <meta property="og:title" content="Diagnostic Criteria, Classification, and Nomenclature for"/>
                    
                        <meta property="og:site_name" content="HBS Medical"/>
                    
                        <meta property="og:url" content="https://hbs.hu/slides/slide/diagnostic-criteria-classification-and-nomenclature-for-59"/>
                    
                        <meta property="og:image" content="https://hbs.hu/web/image/slide.slide/59/image_thumb"/>
                    
                        <meta property="og:description"/>
                    
                
                
                
                    
                        <meta name="twitter:card" content="summary_large_image"/>
                    
                        <meta name="twitter:title" content="Diagnostic Criteria, Classification, and Nomenclature for"/>
                    
                        <meta name="twitter:image" content="https://hbs.hu/web/image/slide.slide/59/image_thumb"/>
                    
                        <meta name="twitter:description"/>
                    
                
            

            
            
                
                    <link rel="alternate" hreflang="hu" href="diagnostic-criteria-classification-and-nomenclature-for-59.html"/>
                
            

            <script type="text/javascript">
                odoo.session_info = {
                    is_admin: false,
                    is_system: false,
                    is_frontend: true,
                    translationURL: '/website/translations',
                    is_website_user: true,
                    user_id: 4
                };
                
            </script>

            <link type="text/css" rel="stylesheet" href="../../web/content/521-3ab7b2c/1/web.assets_common.0.css"/>
            <link type="text/css" rel="stylesheet" href="../../web/content/599-e81acc7/1/web.assets_frontend.0.css"/>
            <link type="text/css" rel="stylesheet" href="../../web/content/600-e81acc7/1/web.assets_frontend.1.css"/>
            
            
            

            <script type="text/javascript" src="../../web/content/524-3ab7b2c/1/web.assets_common.js"></script>
            <script type="text/javascript" src="../../web/content/603-e81acc7/1/web.assets_frontend.js"></script>
            
            
            
        
            </head>
            <body>
                
            
        
            
        
        
            
                
                    
                
                
            
        
        
    
    

            
            
        
    
            
          
        <link rel="stylesheet" type="text/css" href="../../sh_cookie_notice/static/src/css/cookieconsent.min.css"/>
        <script type="text/javascript" src="../../sh_cookie_notice/static/src/js/cookieconsent.min.js"></script>
        

	
	<script type="text/javascript"> 

	 window.addEventListener("load", function(){
 
	var sh_msg = String("Az HBS weboldala sütiket használ a weboldal működtetése, használatának megkönnyítése, a weboldalon végzett tevékenység nyomon követése és releváns ajánlatok megjelenítése érdekében.");
	var sh_esc_msg = encodeURIComponent(sh_msg);
	sh_esc_msg = decodeURIComponent(sh_esc_msg); 
	
  	window.cookieconsent.initialise({
	  "palette": {
	    "popup": {
	      "background": "#000" 
	    },
	    "button": {
	      "background": "#f1d600"
	    }
	  },
	  
	  	  "position": "top",
	  
	
	  
	  "content": {
	    "message": sh_esc_msg,
	    "dismiss": "Elfogadom",
	    "allow": "allow",
	    "link": "Adatvédelmi tájékoztató",
	    "href": "/adatkezelesi-tajekoztato"
	  }
	})});
    </script>
 
   
    <div id="wrapwrap" class="   ">
                <header class=" o_affix_enabled">
                    <nav class="navbar navbar-expand-md navbar-light bg-light">
                        <div class="container">
                            <a href="../../index.html" class="navbar-brand logo">
            <span role="img" aria-label="Logo of HBS Medical" title="HBS Medical"><img src="../../web/image/res.company/1/logo66cf.png?unique=866a03a" class="img img-fluid"/></span>
        </a>
    <button type="button" class="navbar-toggler" data-toggle="collapse" data-target="#top_menu_collapse">
                                <span class="navbar-toggler-icon"></span>
                            </button>
                            <div class="collapse navbar-collapse" id="top_menu_collapse">
                                <ul class="nav navbar-nav ml-auto text-right o_menu_loading" id="top_menu">
                                    
        
            
    
    <li class="nav-item">
        <a role="menuitem" href="../../index.html" class="nav-link ">
            <span>HBS Medical</span>
        </a>
    </li>
    

        
            
    
    <li class="nav-item">
        <a role="menuitem" href="https://covid-19.hbs.hu" class="nav-link " target="_blank">
            <span>COVID-19</span>
        </a>
    </li>
    

        
            
    
    <li class="nav-item">
        <a role="menuitem" href="../../blog/hirek-esemenyek-1.html" class="nav-link ">
            <span>Hírek</span>
        </a>
    </li>
    

        
            
    
    <li class="nav-item">
        <a role="menuitem" href="../../aboutus.html" class="nav-link ">
            <span>Kapcsolat</span>
        </a>
    </li>
    

        
    
                                    
                                </ul>
                            </div>
                        </div>
                    </nav>
                </header>
                <main>
                    
        
        <div class="container mt16">
            <div class="row">
                <div class="col-xl-8 col-lg-8 col-md-12 col-12">
                    

                    <div>
                            
                        <div class="embed-responsive embed-responsive-4by3 embed-responsive-item mb8">
                            <iframe src="../embed/592679.html?page=1" class="o_wslides_iframe_viewer" allowFullScreen="true" height="315" width="420" frameborder="0"></iframe>
                        </div>
                        
                        <div class="row">
                            <h4 class="col-lg-6">Diagnostic Criteria, Classification, and Nomenclature for</h4>
                            <div class="col-lg-6">
                                <div clas="row">
                                    
                                </div>
                            </div>
                        </div>
                        <div class="row">
                            <div class="col-md-8 col-12">
                                <div class="float-left">
                                    <a href="../nyilvanos-anyagok-1.html" title="Channel Nyilvános anyagok" aria-label="Channel Nyilvános anyagok">
                                        <i class="fa fa-circle-o fa-5x" style="color: #875A7B;font-weight: bold;"></i>
                                    </a>
                                </div>
                                <div style="margin-left: 80px">
                                    <p>
                                        <a href="../nyilvanos-anyagok-1.html">Nyilvános anyagok</a>
                                        
                                            <span> / </span>
                                            <a href="../nyilvanos-anyagok-1/category/szakirodalmi-cikkek-3.html">Szakirodalmi cikkek</a>
                                        
                                    </p>
                                    <div>
                                        
        <div class="input-group js_follow" data-id="1" data-object="slide.channel" data-follow="off">
            <input type="email" name="email" class="js_follow_email form-control" placeholder="emailje..."/>
            <div class="input-group-append">
                <button href="#" class="btn btn-secondary js_unfollow_btn">Leiratkozás</button>
                <button href="#" class="btn btn-primary js_follow_btn">Feliratkozás</button>
            </div>
        </div>
    
                                    </div>
                                </div>
                            </div>
                            <div class="col-md-4 d-none d-md-block">
                                <div class="text-right">
                                    <b class="h3 text-muted">1261</b> <span class="text-muted small">views</span>
                                </div>
                                
                                <div class="progress mb0" style="height: 2px;">
                                    <div class="progress-bar" role="progressbar" aria-valuenow="0" aria-valuemin="0" aria-valuemax="100" style="width: 0%;">
                                        <span class="sr-only">0 Likes</span>
                                    </div>
                                </div>
                                <div class="text-muted mt4">
                                    <div class="float-right mb16 text-right">
                                        <span class="oe_slide_js_like" data-href="/slides/slide/like" tabindex="0" data-toggle="popover" data-user-id="4" data-public-user="True" data-slide-id="59">
                                            <i class="fa fa-thumbs-up fa-1x" role="img" aria-label="Likes" title="Likes"></i>
                                            0
                                        </span>
                                        <span class="oe_slide_js_unlike" data-href="/slides/slide/dislike" tabindex="0" data-toggle="popover" data-user-id="4" data-public-user="True" data-slide-id="59">
                                            <i class="fa fa-thumbs-down fa-1x" role="img" aria-label="Dislikes" title="Dislikes"></i>
                                            0
                                        </span>
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="mt8 mb32">
                            <ul class="nav nav-tabs" role="tablist">
                                <li class="nav-item">
                                    <a href="#about" aria-controls="about" role="tab" data-toggle="tab" class="nav-link active">
                                        <i class="fa fa-home"></i> About
                                    </a>
                                </li>
                                <li class="nav-item">
                                    <a href="#share" aria-controls="share" class="nav-link" role="tab" data-toggle="tab">
                                        <i class="fa fa-share-alt"></i> Share
                                    </a>
                                </li>
                                <li class="nav-item">
                                    <a href="#discuss" aria-controls="discuss" role="tab" data-toggle="tab" class="nav-link">
                                        <i class="fa fa-comments-o"></i> Comments
                                    </a>
                                </li>
                                <li class="nav-item">
                                    <a href="#transcript" aria-controls="transcript" class="nav-link" role="tab" data-toggle="tab">
                                        <i class="fa fa-align-justify"></i> Transcript
                                    </a>
                                </li>
                                <li class="nav-item">
                                    <a href="#statistic" aria-controls="statistic" class="nav-link" role="tab" data-toggle="tab">
                                        <i class="fa fa-bar-chart"></i> Statistics
                                    </a>
                                </li>
                            </ul>
                            <div class="tab-content" style="padding: 20px 5px 5px 5px; word-wrap: break-word;">
                                <div role="tabpanel" id="about" class="tab-pane fade active in">
                                    
                                </div>
                                <div role="tabpanel" class="tab-pane fade" id="share">
                                    
    <h4 class="mt0">Share on Social Networks</h4>
    
    <div>
        <a class="o_slides_social_share" social-key="facebook" aria-label="Share on Facebook" title="Share on Facebook" href="https://www.facebook.com/sharer/sharer.php?u=https://hbs.hu/r/9OQ"><i class="fa fa-facebook-square fa-2x"></i></a>
        <a class="o_slides_social_share" social-key="twitter" aria-label="Share on Twitter" title="Share on Twitter" href="https://twitter.com/intent/tweet?text=Diagnostic%20Criteria,%20Classification,%20and%20Nomenclature%20for&amp;url=https://hbs.hu/r/9OQ"><i class="fa fa-twitter fa-2x"></i></a>
        <a social-key="linkedin" class="o_slides_social_share" aria-label="Share on LinkedIn" title="Share on LinkedIn" href="https://www.linkedin.com/shareArticle?mini=true&amp;url=https://hbs.hu/r/9OQ&amp;title=Diagnostic%20Criteria,%20Classification,%20and%20Nomenclature%20for&amp;"><i class="fa fa-linkedin fa-2x"></i></a>
        <a class="o_slides_social_share" social-key="gplus" aria-label="Share on Google Plus" title="Share on Google Plus" href="https://plus.google.com/share?url=https://hbs.hu/r/9OQ"><i class="fa fa-google-plus-square fa-2x"></i></a>
    </div>

    <h4 class="mt-3">Share Link</h4>
    <input type="text" class="form-control" readonly="readonly" onClick="this.select();" value="../../r/9OQ.html"/>
    <span class="form-text">Use permanent link to share in social media</span>

                                    
    <h4 class="mt-3">Share with a friend</h4>
    
    
        <p>Please <a href="../../web/login.html?redirect=https://hbs.hu/slides/slide/diagnostic-criteria-classification-and-nomenclature-for-59"> login </a> to send this document by email!</p>
    

                                    
                                        
    <div class="oe_slide_js_embed_code_widget">
        <h4 class="mt0">Embed in your website</h4>
        <div class="form-group">
            <textarea class="form-control slide_embed_code" readonly="readonly" onClick="this.select();">&lt;iframe src=&quot;https://hbs.hu/slides/embed/59?page=1&quot; class=&quot;o_wslides_iframe_viewer&quot; allowFullScreen=&quot;true&quot; height=&quot;315&quot; width=&quot;420&quot; frameborder=&quot;0&quot;&gt;&lt;/iframe&gt;</textarea>
        </div>
        <div class="form-group">
            <div class="form-text col-xl-3 col-lg-3 col-md-6 col-6">Select page to start with</div>
            <div class="input-group col-xl-3 col-lg-3 col-md-6 col-6">
                <input type="number" value="1" class="form-control"/>
            </div>
        </div>
    </div>

                                    
                                </div>
                                
                                <div role="tabpanel" id="discuss" class="tab-pane fade">
                                    
        <div id="discussion" class="d-print-none o_portal_chatter o_not_editable p-0" data-res_model="slide.slide" data-res_id="59" data-pager_step="10" data-allow_composer="1">
        </div>
    
                                </div>
                                <div role="tabpanel" class="tab-pane fade oe_slides_transcript" id="transcript">
                                    
                                        
                                            <p>8. Int  Urogynecol  J  Pelvic  Floor  Dysfunct  2005;16(Suppl  1): S2–34. [27]  Abrams  P,  Baranowski  A,  Berger  RE,  Fall  M,  Hanno  P, Wesselmann U. A new classification is needed for pelvic pain  syndromes—are  existing  terminologies of spurious diagnostic  authority  bad  for  patients?  J  Urol  2006;175: 1989–90. [28]  Habermacher  GM,  Chason  JT,  Schaeffer  AJ.  Prostatitis/ chronic  pelvic  pain  syndrome.  Annu  Rev  Med  2006;57: 195–206. europeanurology53(2008)60–67 67 </p>
                                        
                                            <p>7. all   patients   with   symptoms   of   pain   and/or urgency  and/or  frequency  not  due  to  common bacterial   urinary   infections   will   be   included. The diagnoses using ESSIC criteria will be validated in   comparison   with   expert   diagnoses   (‘‘gold standard’’)    and    diagnoses    according    to    the NIDDK   criteria.   This   will   allow   the   evaluation of   individual   symptoms   that   warrant   further evaluation for the presence of BPS and the relative contribution of the applied diagnostic procedures, including   cystoscopy   with   hydrodistention   and biopsy  findings,  to  distinguish  patients  with  BPS from those without BPS but one of the confusable diseases. Conflicts of interest None of the authors has conflicts of interest in the publication of this paper. References [1]  Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Work- shop on Interstitial Cystitis, National Institutes of Health, Bethesda,  Maryland,  August  28–29,  1987.  J  Urol  1988; 140:203–6. [2]  Wein  A,  Hanno  P,  Gillenwater  J.  Interstitial  cystitis:  an introduction to the problem. In: Interstitial cystitis. Lon- don: Springer-Verlag, 1990. [3]  Hanno PM, Landis JR, Matthews-Cook Y, Kusek J, Nyberg Jr   L.   The   diagnosis   of   interstitial   cystitis   revisited: lessons  learned from  the  National Institutes  of  Health Interstitial  Cystitis  Database  study.  J  Urol  1999;161: 553–7. [4]  Abrams P, Cardozo L, Fall M, et al. The standardisation of  terminology  of  lower  urinary  tract  function:  report from the Standardisation Sub-committee of the Interna- tional  Continence  Society.  Neurourol  Urodyn  2002;21: 167–78. [5]  Ueda T, Sant GR, Hanno PM, Yoshimura N, editors. Pro- ceedings of the International Consultation on Interstitial Cystitis. March 28–30, 2003. Kyoto, Japan. Int J Urol 2003; 10(Suppl i–iv):S1–70. [6]  Fries   JF,   Hochberg   MC,   Medsger   Jr   TA,   Hunder   GG, Bombardier  C.  Criteria  for  rheumatic  disease.  Different types and different functions.  The American College of Rheumatology Diagnostic and Therapeutic Criteria Com- mittee. Arthritis Rheum 1994;37:454–62. [7]  Nordling J, Anjum FH, Bade JJ, et al. Primary evaluation of patients suspected of having interstitial cystitis (IC). Eur Urol 2004;45:662–9. [8]  Fall M, Baranowski AP, Fowler CJ, et al. EAU guidelines on chronic pelvic pain. Eur Urol 2004;46:681–9. [9]  Hanno  P.  Toward  optimal  health:  Philip  Hanno,  M.D., M.P.H.,   discusses   improved   management   of   painful bladder syndrome (interstitial cystitis). Interview by Jodi R. Godfrey. J Womens Health (Larchmt) 2007;16:3–8. [10]  Abrams  P.  Urgency:  the  key  to  defining  the  overactive bladder. BJU Int 2005;96(Suppl 1):1–3. [11]  Sirinian E, Azevedo K, Payne CK. Correlation between 2 interstitial cystitis symptom instruments. J Urol 2005;173: 835–40. [12]  Merskey  H,  Bogduk  N.  Classification  of  chronic  pain, descriptions of chronic pain syndromes and definitions of pain terms. IASP Press; 2002. [13]  Trachtenberg  J,  Roehrborn  CG.  Updated  results  of  a randomized, double-blind, multicenter sham-controlled trial   of   microwave   thermotherapy   with   the   Dornier Urowave in patients with symptomatic benign prostatic hyperplasia. Urowave Investigators Group. World J Urol 1998;16:102–8. [14]  Tsai YS, Lin JS, Tong YC, et al. Transurethral microwave thermotherapy for symptomatic benign prostatic hyper- plasia:  short-term  experience  with  Prostcare.  Urol  Int 2000;65:89–94. [15]  Wagrell L, Schelin S, Nordling J, et al. Three-year follow- up of feedback microwave thermotherapy  versus TURP for  clinical  BPH:  a  prospective  randomized  multicenter study. Urology 2004;64:698–702. [16]  Warren  JW,  Meyer  WA,  Greenberg  P,  Horne  L,  Diggs  C, Tracy  JK.  Using  the  International  Continence  Society’s definition of painful bladder syndrome. Urology 2006;67: 1138–42, discussion 1142–3. [17]  Abrams  P,  Hanno  P,  Wein  A.  Overactive  bladder  and painful bladder syndrome: there need not be confusion. Neurourol Urodyn 2005;24:149–50. [18]  Blaivas JG, Panagopoulos G, Weiss JP, Somaroo C, Chaikin DC.  The  urgency  perception  score:  validation  and  test- retest. J Urol 2007;177:199–202. [19]  Diggs C, Meyer WA, Langenberg P, Greenberg P, Horne L, Warren JW. Assessing urgency in interstitial cystitis/pain- ful bladder syndrome. Urology 2007;69:210–4. [20]  Parsons CL, Greenberger M, Gabal L, Bidair M, Barme G. The role  of  urinary potassium in  the  pathogenesis  and diagnosis  of  interstitial  cystitis.  J  Urol  1998;159:1862–6, discussion 1866–7. [21]  Chambers GK, Fenster HN, Cripps S, Jens M, Taylor D. An assessment  of  the  use  of  intravesical  potassium  in  the diagnosis of interstitial cystitis. J Urol 1999;162:699–701. [22]  Hornby AS, Cowie AP, editors. Oxford advanced learner’s dictionary  of  current  English.  Oxford,  United  Kingdom: University Press, 1985. p. 946. [23]  Peeker R, Fall M. Toward a precise definition of interstitial cystitis:  further  evidence  of  differences  in  classic  and nonulcer disease. J Urol 2002;167:2470–2. [24]  Hanno PM. Painful bladder syndrome/interstitial cystitis and   related   disorders.   In:   Campbell-Walsh   Urology e-dition, ed. 9, chap. 10. Elsevier, Mosby, Saunders; 2007. [25]  Janicki TI. Chronic pelvic pain as a form of complex regional pain syndrome. Clin Obstet Gynecol 2003;46:797–803. [26]  Hanno P, Keay S, Moldwin R, Van Ophoven A. Interna- tional Consultation on IC - Rome, September 2004/Forging an International Consensus: progress in painful bladder syndrome/interstitial   cystitis.   Report   and   abstracts. europeanurology53(2008)60–67 66 </p>
                                        
                                            <p>6. diseases)  and  to  confirm  the  final  diagnosis.  BPS may occur together with confusable diseases such as chronic or remitting urinary infections or endo- metriosis.   Cystoscopy   with   hydrodistention   and biopsies might in this situation document positive signs  of  BPS  thereby  making  a  double  diagnosis more  probable.  For  therapeutic  studies  it  makes sense  to  exclude  patients  who  also  have  a  con- fusable disease because symptoms and signs may be caused by BPS, the confusable disease, or by both. For prevalence studies of BPS, on the other hand, all cases with BPS should be included, also those with a confusable  disease.  This  approach  eliminates  the need  for  separate  diagnostic  criteria  for  clinical practice and scientific studies. 4.5.   Why do we need various BPS types? Unravelling the cause of a disease usually begins with grouping patients with similar symptoms and signs. The hypothesis is that these patients have a disease with   the   same   etiopathogenesis   that   is   better recognized in homogeneous than in heterogeneous groups.  This  has  been  the  reason  for  dividing  BPS patients  into  subgroups  (types)  based  on  positive signs.  It  is  worth  noting  that  the  Hunner  type  of disease stands out as a specific type, not only cysto- scopically but also with reference to histopathology, response to treatment, and complications [8,23] . 4.6.   Why do we propose to change the name of IC? Hanno  recently  stated  that  the  term  IC  was  not descriptive of the clinical syndrome or the pathologic findings  in  many  cases.  Moreover,  the  term  IC  is misleading because it directs attention only to the urinary bladder and inflammation [24] . The name IC excludes  patients  with  typical  IC  symptoms  but normal  cystoscopic  and  histologic  findings  from disease classification in many countries around the world. The inability to classify these patients might have severe negative consequences for the patients, for  example,  in  therapeutic,  personal,  social,  and many   other   aspects.  IC,  originally  considered   a bladder  disease,  is  now  considered  a  chronic  pain syndrome [25] .  These  perceptions  have  led  to  the current effort to reconsider the name of the disorder [8,24,26,27] . It is also the contention of the ESSIC that the existing terminology of IC hampers development in this area. 4.7.   Why do we propose to choose BPS as the new name? For some time now there has been much work going on in international organizations to create a logical and  workable  terminology  for  chronic  (persistent) pain  conditions.  For  background  information  we refer to the 2007 Guidelines on Chronic Pelvic Pain issued by the European Association of Urology (EAU) [8] .  The  EAU  definitions  are  in  line  with  recent recommendations for terminology from the ICS [4] and use the axial structure of the IASP classification [12] . This implies a taxonomy-like approach under the umbrella term of chronic pelvic pain syndrome. Further identification is based on the primary organ that  appears  to  be  affected  on  clinical  grounds. Urologic  pelvic  pain  syndromes  are  divided  into bladder  pain  syndrome,  urethral  pain  syndrome, penile pain syndrome, prostate pain syndrome, and others.  More  specific  terminology  is  based  on  the identification   of,   for   example,   inflammation   or infection [27,28] . The classification system of chronic pelvic  pain  syndromes  aims  to  draw  together  the expertise of many specialist groups. The impact of the classification of chronic pelvic pain syndromes thus  goes  far  beyond  the  scope  of  IC.  Another essential   feature   is   that   the   nomenclature   and knowledge of pathophysiologic mechanisms do not conflict with each other. In this context, the name bladder pain syndrome was considered the best new name for IC to date, because the name is in line with the  other  chronic  pelvic pain  syndromes and  is in balance  with  the  clinical  presentation  of  the  syn- drome and the level of knowledge of its pathophy- siology. We realize that changing the name of IC into BPS may have emotional implications, understandably for patients, but also for patient organizations with a   scope   limited   to   IC   and   for   insurance   and reimbursement in different health systems around the    world.    Considering    these    consequences, although BPS is the name of choice, ESSIC agrees that   including   IC   in   the   overall   term   (BPS/IC) could be used in parallel to BPS during a transition period. In  this  context,  it  is  worth  remembering  that  a subgroup of BPS patients (representing the Hunner type  of  disease)  presents  interstitial  inflammation and is thus fulfilling the requirements of the original term of IC. 4.8.   Next steps A worldwide evidence-based consensus is lacking on  whether  chronic  pelvic  pain  perceived  to  be related   to   the   bladder   is   a   prerequisite   for   a diagnosis  of  BPS  and  on  the  value  of  cystoscopy with hydrodistention and biopsies for the manage- ment of patients with BPS. For this reason, ESSIC will start a prospective validation study in which europeanurology53(2008)60–67 65 </p>
                                        
                                            <p>5. 4.2.   Why is pain a prerequisite? BPS is characterized by urinary bladder pain [9,10] .A recent study, however, demonstrated a correlation between   pain   bother   in   the   IC   problem   index (burning,  discomfort,  pain,  or  pressure)  and  the presence of pain in the IC symptom index of only 0.7 [11] ,  This  finding  underscores  that  many  patients report a sensation of pressure or discomfort in the bladder/pelvic area and do not report this sensation as  pain  but  rather  as  urgency  (see  below).  The International  Association  for  the  Study  of  Pain; www.iasp-pain.org ;  [IASP])  definition  of  pain  is: ‘‘An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage’’ [12] . Patients having  microwave  treatment  for  benign  prostatic obstruction producing tissue damage at the bladder neck  report  the  same  sensation  of  pressure  and discomfort   in   the   bladder   region [13–15] .   The sensation is therefore by definition a pain sensation, but not described as such by the patient. Pain   or   the   equivalent   pressure,   discomfort perceived to be related to the bladder was, therefore, considered to be a prerequisite for the description of symptoms  on  the  basis  of  which  patients  should undergo further investigations for BPS. The increase of   pain   on   bladder   filling   was   left   out   of   the description  because  this  association  is  not  always present [9,16,17] . 4.3.   Why is urgency not included in the description of patients who need further evaluation for BPS? Urgency is defined by the ICS as the complaint of a sudden  compelling  desire  to  pass  urine,  which  is difficult to defer [4] . BPS is commonly mistaken for overactive    bladder    (OAB)    because    the    term ‘‘urgency’’ is used to describe the symptoms of both disorders.  For  some  women,  urgency  is  used  to indicate the heightened need to make it to a toilet quickly to avoid getting wet, whereas other women consider urgency to mean a need to void as a way of avoiding intensifying pain, pressure, or discomfort. The first group is most likely to have OAB, and the latter group can be expected to have BPS [9] . Urinary urgency was left out of the description of patients   who   need   further   evaluation   for   the presence of BPS for several reasons. First, urgency is   the   key   symptom   of   OAB [10,17] ,   a   major confusable  disease  for  BPS,  that  is  10  times  more common than is BPS [9] . Second, the clinical aspects of  urgency  are  complex [4,9,17–21] .  At  a  meeting arranged by the Association of Reproductive Health Professionals ( www.arhp.org ) in the United States in February 2007 involving 33 urologists, gynecologists, and   nurses   it   was   proposed   to   use   the   term ‘‘persistent   urge’’   instead   of   urgency   to   avoid confusion with OAB (pers. comm., P. Hanno, 2007). Many patients find the strong, discomfortable urge to void the most dominant and disabling part of their symptomatology, so patients (and doctors) are often confused because, with the present terminology, a patient  is  not  allowed  to  use  the  word  urge  to describe  complaints.  In  the  Oxford Advanced  Lear- ner’s Dictionary of Current English urge is defined as ‘‘a strong   desire,’’   whereas   urgency   is   defined   as ‘‘needing  prompt  decision  or  action’’ [22] .  So  the words  urgency  and  urge  describe  very  well  the difference between the sensation felt by the patient with OAB and the patient with BPS. Persistent urge was therefore included in the definition as a typical symptom,  such  as  frequency.  It  must  be  stressed that   the   presence   of   these   symptoms   is   not necessary to suspect or diagnose BPS. 4.4.   Why should confusable diseases be excluded? In evidence-based medicine, diagnoses are based on medical history, physical examination, and appro- priate  clinical  investigations  to  eliminate  diseases from  the  list  of  differential  diagnoses  (confusable Fig. 1 – Schematic representation of the proposed approach for the diagnosis of bladder pain syndrome (BPS). europeanurology53(2008)60–67 64 </p>
                                        
                                            <p>4. an  indication  on  how  they  can  be  recognized  or excluded. 3.4.   Classification of BPS Consensus was obtained that for the documentation of  positive  signs  for  the  diagnosis  of  BPS,  hydro- distention at cystoscopy  was a  prerequisite  and if indicated a biopsy (to document histologic details of BPS).  Cystoscopic  features  that  were  accepted  as positive signs of BPS were glomerulations grade 2–3 or  Hunner’s  lesions  or  both  (see  below).  Biopsy findings that were accepted as positive signs of BPS were  inflammatory  infiltrates  and/or  granulation tissue  and/or  detrusor  mastocytosis  and/or  intra- fascicular fibrosis. 3.5.   Hunner’s lesion Hunner’s ‘‘ulcer’’ is not a chronic ulcer but rather a distinctive inflammatory lesion presenting a char- acteristic  deep  rupture  through  the  mucosa  and submucosa  provoked  by  bladder  distention.  The word   ‘‘ulcer’’   suggests   that   it   can   be   seen   at cystoscopy without hydrodistention. Consequently, the name Hunner’s ulcer was replaced by Hunner’s lesion.   The    following    definition    by    Fall   was accepted.  ‘‘The  Hunner’s  lesion  typically  presents as a circumscript, reddened mucosal area with small vessels radiating towards a central scar, with a fibrin deposit or coagulum attached to this area. This site ruptures  with  increasing  bladder  distension,  with petechial  oozing  of  blood  from  the  lesion  and  the mucosal  margins  in  a  waterfall  manner.  A  rather typical,  slightly  bullous  edema  develops  post-dis- tension with varying peripheral extension.’’ 3.6.   Types of BPS BPS shows large variations among patients in clinical presentation, complaints, quality of life, cystoscopic and biopsy findings, response to treatment, clinical course, and prognosis. It was generally appreciated that  these  characteristics  may  be  correlated  only to   some   extent.   Diagnostic   criteria   and  disease classification   should   facilitate   future   studies   on these relationships. Consequently, types of BPS were defined based on findings used to document positive signs  for  the  diagnosis  of  BPS.  The  name  BPS  will be  followed  by  a  type  indication  that  consists  of two symbols: symbols 1, 2, or 3 indicate findings at cystoscopy with hydrodistention and symbols A, B or C of biopsy findings. X indicates that no cystoscopy with  hydrodistention  (first  symbol)  or  no  biopsy (second symbol) was done ( Table 2 ). BPS types thus also  allow  classification  of  patients  with  normal findings  at  cystoscopy  with  hydrodistention  and normal  biopsies  as  long  as  they  fulfill  the  patient selection   criteria   and   confusable   diseases   are excluded (BPS type 1A; Fig. 1 and Table 2 ). 4.    Discussion 4.1.   Why do we need new criteria? The  NIDDK  criteria  for  the  diagnosis  of  IC  were intended for use in scientific studies. These criteria, however, do not recognize more than one third of patients   considered   to   have   IC   by   experts [3] . Patients under the age of 18 yr are excluded as are those  with  a  bladder  capacity  of &gt; 350 ml,  thus making  it  difficult  to  study  early  stages  of  the disease.   These   considerations   make   the   NIDDK criteria  less  useful  in  clinical  situations  and  limit their value in scientific studies because the criteria only  recognize  a  biased  minority  of  the  patient population.   The   need   for   the   design   of   new diagnostic criteria is obvious. To avoid unacceptable discrepancies between scientific studies and clinical practice,   it   was   considered   essential   that   new diagnostic criteria could be used in both situations. Table 2 – Classification of types of bladder pain syndrome on the basis of findings at cystoscopy with hydrodistention and of biopsies Cystoscopy with hydrodistention Not done                          Normal                          Glomerulations a Hunner’s lesion b Biopsy Not done                                             XX                                          1X                                                 2X                                                            3X Normal                                                XA                                          1A                                                 2A                                                            3A Inconclusive                                       XB                                          1B                                                 2B                                                            3B Positive c XC                                          1C                                                 2C                                                            3C a Cystoscopy: glomerulations grade 2–3. b With or without glomerulations. c Histology showing inflammatory infiltrates and/or detrusor mastocytosis and/or granulation tissue and/or intrafascicular fibrosis. europeanurology53(2008)60–67 63 </p>
                                        
                                            <p>2. 1.    Introduction The National Institute of Diabetes and Digestive and Kidney  Disease  (NIDDK)  formulated  criteria  for  a diagnosis of interstitial cystitis (IC) in 1987 and 1988 [1,2] . These criteria were meant for scientific studies. They  have  worked  well  in  a  scientific  setting,  but were fulfilled by only one third of patients thought to have IC by experts [3] . The International Continence Society  (ICS)  defined  the  term  ‘‘painful  bladder syndrome’’  (PBS)  as  ‘‘the  complaint  of  suprapubic pain related to bladder filling, accompanied by other symptoms  such  as  increased  daytime  and  night- time  frequency,  in  the  absence  of  proven  urinary infection or other obvious pathology’’ [4] . The name IC is reserved for PBS with typical cystoscopic and histologic features. Logically IC should include some form  of  inflammation  in  the  deeper  layers  of  the bladder  wall,  whereas  PBS  should  include  pain  in the  region  of  the  bladder.  At  the  International Consultation on Interstitial Cystitis in Japan (ICICJ) in  2003,  it  became  clear  that  the  evaluation  and diagnosis  of  patients  differed  enormously  among centers in Europe, North America, and Japan [5] and that a new approach was urgently needed. Criteria  for  a  diagnosis  are  needed  only  if  the target disease may be confused with other diseases (confusable  diseases)  because  of  overlapping  fea- tures [6] . For a diagnosis, the target disease has to be  recognized  in  a  pool  of  confusable  diseases  in one  of  two  ways:  by  recognition  of  the  specific combination of features of the target disease or by exclusion of confusable diseases. For the diagnosis of bladder pain syndrome (BPS), the name we prefer for PBS/IC (see below), both methods might be used because:  Confusable diseases are more common than BPS, so recognition is mandatory because many can be treated.  Failure  to  diagnose  a  confusable  disease  would automatically incorrectly yield a diagnosis of BPS.  Patients may have a confusable disease plus BPS. The diagnosis of BPS is thus made on the basis of exclusion of confusable diseases and confirmation by  the  recognition  of  the  presence  of  the  specific combination of symptoms and signs of BPS. If the main  urinary  symptoms  are  not  explained  by  a single  diagnosis  (confusable  disease  or  BPS),  the presence of a second diagnosis is possible. Symptoms and signs for use in diagnostic criteria do not need to be specific for the target disease. On the contrary, if a specific symptom or sign existed for the target disease, a diagnosis would only require the presence of the specific feature and diagnostic criteria would not be necessary. 2.    Methods The  European  Society  for  the  Study  of  Interstitial  Cystitis (ESSIC)  held  meetings  in  2003  and  2004  (Copenhagen,  Den- mark) on standardization of medical history, physical exam- ination, laboratory tests, symptoms evaluation, urodynamics, and  the  technique  and   classification  of   cystoscopic  and histologic   findings [7] .   Briefly,   glomerulations   represent bleeding  at  cystoscopy  with  hydrodistention,  with  grade  2 being  large  submucosal  bleeding  (ecchymosis)  and  grade  3 Confusable disease Diagnostic criteria Frequency Hunner’s ulcer Interstitial cystitis Pain Painful bladder syndrome Urgency Please visit www.eu-acme.org/ europeanurology to read and answer questions on-line. The EU-ACME credits will then be attributed automatically. Results: It was agreed to name the disease bladder pain syndrome (BPS). BPS would be diagnosed on the basis of chronic pelvic pain, pressure, or discomfort perceived to be related to the urinary bladder accompanied by at least one other urinary symptom such as persistent urge to void or urinary frequency. Confusable diseases as the cause of the symptoms must  be  excluded.  Classification  of  BPS  types  might  be  performed according to findings at cystoscopy with hydrodistention and morpho- logic findings in bladder biopsies. The presence of other organ symptoms as  well  as  cognitive,  behavioral,  emotional,  and  sexual  symptoms, should be addressed. Conclusions: The name IC has become misleading and is replaced by BPS. This name is in line with recent nomenclature recommendations by the European Association of Urology and is based on the axial structure of the  International  Association  for  the  Study  of  Pain  classification.  To facilitate  the  change  of  the  name,  ESSIC  agreed  to  include  IC  in  the overall term (BPS/IC) during this transition period. # 2007 European Society for the Study of Bladder Pain Syndrome/Interstitial Cystitis. Published by Elsevier B.V. on behalf of European Association of Urology. europeanurology53(2008)60–67 61 </p>
                                        
                                            <p>3. diffuse  global  mucosal  bleeding.  Detrusor  mastocytosis  is defined as mast cell counts exceeding 28 mast cells/mm 2 [7] .At ESSIC  meetings  in  2005  in  Baden  and  2006  in  London,  the following approach to the diagnosis of BPS was discussed:  Selection of patients who need further evaluation for the presence of BPS  Exclusion of relevant confusable diseases as the main cause of urinary symptoms  Classification of BPS 3.    Results 3.1.   Name Consensus was obtained that the name bladder pain syndrome  (BPS)  better  complies  with  our  present knowledge and current nomenclature of other pain syndromes than the name IC or PBS. Omitting the name  ‘‘interstitial   cystitis’’  might   cause   serious problems  in  different  health  systems  by  affecting reimbursement,   possibility   for   patients   to   gain disability benefits, and so forth, and it was therefore decided  that  the  name  bladder  pain  syndrome/ interstitial  cystitis  (BPS/IC)  could  be  used  parallel with BPS for the time being. 3.2.   Selection of patients It was agreed that BPS would be diagnosed on the basis of chronic ( &gt; 6mo [8] ) pelvic pain, pressure, or discomfort perceived to be related to the urinary bladder accompanied by at least one other urinary symptom   such   as   persistent   urge   to   void   or frequency.  Confusable  diseases  as  the   cause  of the  symptoms  must  be  excluded.  Further  docu- mentation  and  classification  of  BPS  might  be  per- formed  according  to  findings  at  cystoscopy  with hydrodistention and morphologic findings in bladder biopsies. The presence of other organ symptoms as well as cognitive, behavioral, emotional, and sexual symp- toms should be addressed. 3.3.   Confusable diseases Diseases   that   were   discussed   and   accepted   as confusable diseases for BPS are listed in Table 1 with Table 1 – Confusable diseases for bladder pain syndrome Confusable disease                                                                                                            Excluded or diagnosed by a Carcinoma and carcinoma in situ                                                                        Cystoscopy and biopsy Infection with Common intestinal bacteria                                                                              Routine bacterial culture Chlamydia trachomatis, Ureaplasma urealyticum Special cultures Mycoplasma hominis, Mycoplasma genitalium Corynebacterium urealyticum , Candida species Mycobacterium tuberculosis Dipstick; if ‘‘sterile’’ pyuria culture for M. tuberculosis Herpes simplex and human papilloma virus                                                  Physical examination Radiation                                                                                                               Medical history Chemotherapy, including immunotherapy with cyclophosphamide          Medical history Anti-inflammatory therapy with tiaprofenic acid                                          Medical history Bladder-neck obstruction and neurogenic outlet obstruction                      Uroflowmetry and ultrasound Bladder stone                                                                                                        Imaging or cystoscopy Lower ureteric stone                                                                                           Medical history and/or hematuria: upper urinary tract imaging such CT or IVP Urethral diverticulum                                                                                             Medical history and physical examination Urogenital prolapse                                                                                                 Medical history and physical examination Endometriosis                                                                                                          Medical history and physical examination Vaginal candidiasis                                                                                                 Medical history and physical examination Cervical, uterine, and ovarian cancer                                                                  Physical examination Incomplete bladder emptying (retention)                                                            Postvoid residual urine volume measured by ultrasound scanning Overactive bladder                                                                                                  Medical history and urodynamics Prostate cancer                                                                                                        Physical examination and PSA Benign prostatic obstruction                                                                                 Uroflowmetry and pressure-flow studies Chronic bacterial prostatitis                                                                                  Medical history, physical examination, culture Chronic non-bacterial prostatitis                                                                          Medical history, physical examination, culture Pudendal nerve entrapment                                                                                  Medical history, physical examination, nerve block may prove diagnosis Pelvic floor muscle-related pain                                                                           Medical history, physical examination CT = computed tomography; IVP = intravenous pyelogram; PSA = prostate-specific antigen. a The diagnosis of a confusable disease does not necessarily exclude a diagnosis of BPS. europeanurology53(2008)60–67 62 </p>
                                        
                                            <p>1. Review – Pelvic Pain Diagnostic Criteria, Classification, and Nomenclature for Painful Bladder Syndrome/Interstitial Cystitis: An ESSIC Proposal Joop P. van de Merwe a , Jørgen Nordling b , * , Pierre Bouchelouche c , Kirsten Bouchelouche c , Mauro Cervigni d , L. Kurosch Daha e , Suzy Elneil f , Magnus Fall g , Gero Hohlbrugger h , Paul Irwin i , Svend Mortensen b , Arndt van Ophoven j , John L. Osborne k , Ralph Peeker g , Benedikte Richter b , Claus Riedl l , Jukka Sairanen m , Martina Tinzl n , Jean-Jacques Wyndaele o a Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands b Herlev Hospital, University of Copenhagen, Herlev, Denmark c Koege Hospital, University of Copenhagen, Copenhagen, Denmark d S. Carlo-IDI Hospital, Rome, Italy e Hospital Hietzing, Vienna, Austria f National Hospital for Neurology and Neurosurgery, London, United Kingdom g Sahlgrens Academy, Go  ̈ teborg University, Sweden h University of Innsbruck, Innsbruck, Austria i Leighton Hospital, Crewe, Cheshire, United Kingdom j University of Mu  ̈ nster, Mu  ̈ nster, Germany k University College Hospital London, United Kingdom l Thermen Klinikum, Baden, Austria m Helsinki University Hospital, Helsinki, Finland n University Hospital Vienna, Vienna, Austria o University of Antwerp, Antwerp, Belgium europeanurology53(2008)60–67 available at www.sciencedirect.com journal homepage: www.europeanurology.com Article info Article history: Accepted September 10, 2007 Published online ahead of print on September 20, 2007 Keywords: Bladder pain syndrome BPS Interstitial cystitis IC Chronic pelvic pain Abstract Objectives: Because  the  term  ‘‘interstitial  cystitis’’  (IC)  has  different meanings  in  different  centers  and  different  parts  of  the  world,  the European Society for the Study of Interstitial Cystitis (ESSIC) has worked to create a consensus on definitions, diagnosis, and classification in an attempt  to  overcome  the  lack  of  international  agreement  on  various aspects of IC. Methods: ESSIC has discussed definitions, diagnostic criteria, and disease classification in four meetings and extended e-mail correspondence. *  Corresponding author. Department of Urology, Herlev Hospital, DK2730 Herlev, Denmark. Tel. +45 28493658; Fax: +45 44882860. E-mail address: <a href="../../cdn-cgi/l/email-protection.html" class="__cf_email__" data-cfemail="cea4a0a1bcaaa2a7a0a98eaaafaaa2a0abbae0aaa5">[email&#160;protected]</a> (J. Nordling). 0302-2838/$ – see back matter # 2007 European Society for the Study of Bladder Pain Syndrome/Interstitial Cystitis. Published by Elsevier B.V. on behalf of European Association of Urology.                                                                                              doi: 10.1016/j.eururo.2007.09.019 </p>
                                        
                                            <p></p>
                                        
                                    
                                </div>
                                <div role="tabpanel" class="tab-pane fade" id="statistic" slide-url="../../r/9OQ.html">
                                    <div class="row">
                                        <div class="col-lg-4">
                                            <h4 class="mt0 oe_slides_statistics_title">Nézetek</h4>
                                            <ul class="list-group">
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill">1261</span>
                                                    <i class="fa fa-play"></i> Total Views
                                                </li>
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill">937</span>
                                                    <i class="fa fa-circle-o"></i> Website Views
                                                </li>
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill">324</span>
                                                    <i class="fa fa-code"></i> Embedded Views
                                                </li>
                                            </ul>
                                        </div>

                                        <div class="col-lg-4">
                                            <h4 class="mt0 oe_slides_statistics_title">Műveletek</h4>
                                            <ul class="list-group">
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill" id="total-share">0</span>
                                                    <i class="fa fa-share-alt"></i> Social Shares
                                                </li>
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill">0</span>
                                                    <i class="fa fa-thumbs-up"></i> Likes
                                                </li>
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill">0</span>
                                                    <i class="fa fa-thumbs-down"></i> Nemkedvelések
                                                </li>
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill">0</span>
                                                    <i class="fa fa-comments-o"></i> Comments
                                                </li>
                                            </ul>
                                        </div>

                                        <div class="col-lg-4">
                                            <h4 class="mt0 oe_slides_statistics_title">Share count</h4>
                                            <ul class="list-group">
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill" id="facebook-badge">0</span>
                                                    <i class="fa fa-facebook-square"></i> Facebook
                                                </li>
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill" id="twitter-badge">0</span>
                                                    <i class="fa fa-twitter-square"></i> Twitter
                                                </li>
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill" id="linkedin-badge">0</span>
                                                    <i class="fa fa-linkedin-square"></i> LinkedIn
                                                </li>
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill" id="google-badge">0</span>
                                                    <i class="fa fa-google-plus-square"></i> Google+
                                                </li>
                                            </ul>
                                        </div>
                                    </div>
                                    <div class="row">
                                        <div class="col-lg-12">
                                            <h4 class="mt0"> Embeds
                                                <span class="badge badge-pill float-right">
                                                    4
                                                </span>
                                            </h4>
                                            <ul class="list-group" style="height: 150px;overflow: auto;">
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill">6</span>
                                                    www.hbs.hu
                                                </li><li class="list-group-item">
                                                    <span class="badge badge-pill">11</span>
                                                    hbs.hu
                                                </li><li class="list-group-item">
                                                    <span class="badge badge-pill">1</span>
                                                    novotrade.hu
                                                </li><li class="list-group-item">
                                                    <span class="badge badge-pill">2</span>
                                                    odoo.hbs.hu
                                                </li>
                                            </ul>
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
                <div class="col-xl-4 col-lg-4 col-md-12 col-12">
                    <ul class="nav nav-tabs" role="tablist">
                        <li class="nav-item"><a aria-controls="related" href="#related" class="nav-link active" data-toggle="tab">Kapcsolódó</a></li>
                        <li class="nav-item"><a aria-controls="most_viewed" href="#most_viewed" class="nav-link" data-toggle="tab">Most Viewed</a></li>
                    </ul>
                    <div class="tab-content">
                        <div role="tabpanel" id="related" class="tab-pane active mt4">
                            <div class="card">
                                <ul class="list-unstyled card-body">
                                    
                                    
                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="cuaj-5-6-e136-17.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/17/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="cuaj-5-6-e136-17.html"><h6 class="mb-1">cuaj-5-6-e136</h6></a>
            <small class="text-muted">
                1557 Views . <timeago class="timeago" datetime="2019-10-31 13:27:48.254982"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="minimally-invasive-device-for-intravesical-instillation-lovasz-2019-international-journal-of-urology-18.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/18/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="minimally-invasive-device-for-intravesical-instillation-lovasz-2019-international-journal-of-urology-18.html"><h6 class="mb-1">Minimally invasive device for intravesical instillation-Lovasz-2019-International_Journal_of_Urology</h6></a>
            <small class="text-muted">
                1503 Views . <timeago class="timeago" datetime="2019-10-31 13:28:10.125299"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="cikk-a-neurourology-and-urodynamics-ban-2018-19.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/19/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="cikk-a-neurourology-and-urodynamics-ban-2018-19.html"><h6 class="mb-1">Cikk a Neurourology and Urodynamics-ban 2018.</h6></a>
            <small class="text-muted">
                1472 Views . <timeago class="timeago" datetime="2019-10-31 13:28:23.618732"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="ic-bps-treatment-checklist-20.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/20/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="ic-bps-treatment-checklist-20.html"><h6 class="mb-1">IC-BPS Treatment Checklist</h6></a>
            <small class="text-muted">
                1497 Views . <timeago class="timeago" datetime="2019-10-31 13:28:50.163748"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="ic-bps-diagnostic-algorhytm-21.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/21/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="ic-bps-diagnostic-algorhytm-21.html"><h6 class="mb-1">IC-BPS diagnostic algorhytm.</h6></a>
            <small class="text-muted">
                1486 Views . <timeago class="timeago" datetime="2019-10-31 13:29:57.450898"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="glycosaminoglycan-therapy-for-bladder-diseases-22.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/22/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="glycosaminoglycan-therapy-for-bladder-diseases-22.html"><h6 class="mb-1">Glycosaminoglycan Therapy for Bladder Diseases</h6></a>
            <small class="text-muted">
                1383 Views . <timeago class="timeago" datetime="2019-10-31 13:30:10.980936"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="essic-2017-budapest-abstracts-23.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/23/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="essic-2017-budapest-abstracts-23.html"><h6 class="mb-1">ESSIC 2017 Budapest abstracts</h6></a>
            <small class="text-muted">
                1462 Views . <timeago class="timeago" datetime="2019-10-31 13:30:38.129948"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="prevalence-of-symptoms-of-bladder-pain-syndrome-2011-24.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/24/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="prevalence-of-symptoms-of-bladder-pain-syndrome-2011-24.html"><h6 class="mb-1">Prevalence of Symptoms of Bladder Pain Syndrome 2011</h6></a>
            <small class="text-muted">
                1302 Views . <timeago class="timeago" datetime="2019-10-31 13:30:57.131521"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="the-urinary-microbiota-of-men-and-women-and-its-changes-in-women-during-bacterial-vaginosis-and-antibiotic-treatment-2017-25.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/25/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="the-urinary-microbiota-of-men-and-women-and-its-changes-in-women-during-bacterial-vaginosis-and-antibiotic-treatment-2017-25.html"><h6 class="mb-1">The urinary microbiota of men and women and its changes in women during bacterial vaginosis and antibiotic treatment. 2017</h6></a>
            <small class="text-muted">
                1360 Views . <timeago class="timeago" datetime="2019-10-31 13:35:55.689470"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="interstitial-cystitis-associated-urinary-metabolites-identified-by-mass-spectrometry-based-metabolomics-analysis-2016-26.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/26/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="interstitial-cystitis-associated-urinary-metabolites-identified-by-mass-spectrometry-based-metabolomics-analysis-2016-26.html"><h6 class="mb-1">Interstitial Cystitis-Associated Urinary Metabolites Identified by Mass-Spectrometry Based Metabolomics Analysis. 2016</h6></a>
            <small class="text-muted">
                1297 Views . <timeago class="timeago" datetime="2019-10-31 13:36:14.959707"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="pentosan-polysulfate-sodium-for-therapy-of-ic-urology-1990-27.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/27/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="pentosan-polysulfate-sodium-for-therapy-of-ic-urology-1990-27.html"><h6 class="mb-1">PENTOSAN POLYSULFATE SODIUM FOR THERAPY of IC Urology 1990</h6></a>
            <small class="text-muted">
                1412 Views . <timeago class="timeago" datetime="2019-10-31 13:37:27.415502"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="interstitial-cystitis-intravesical-therapy-tau-06-s2-s171-2017-28.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/28/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="interstitial-cystitis-intravesical-therapy-tau-06-s2-s171-2017-28.html"><h6 class="mb-1">Interstitial cystitis intravesical therapy tau-06-S2-S171 2017</h6></a>
            <small class="text-muted">
                1366 Views . <timeago class="timeago" datetime="2019-10-31 13:38:04.204366"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="novel-targeted-bladder-drug-delivery-systems-rru-7-169-2015-29.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/29/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="novel-targeted-bladder-drug-delivery-systems-rru-7-169-2015-29.html"><h6 class="mb-1">Novel targeted bladder drug-delivery systems rru-7-169 2015</h6></a>
            <small class="text-muted">
                1487 Views . <timeago class="timeago" datetime="2019-10-31 13:38:18.425299"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="intravesical-administration-of-combined-hyaluronic-acid-ha-and-chondroitin-sulfate-cs-for-the-treatment-of-female-recurrent-urinary-tract-infections-2016-bmjopen-2015-009669-30.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/30/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="intravesical-administration-of-combined-hyaluronic-acid-ha-and-chondroitin-sulfate-cs-for-the-treatment-of-female-recurrent-urinary-tract-infections-2016-bmjopen-2015-009669-30.html"><h6 class="mb-1">Intravesical administration of combined hyaluronic acid (HA) and chondroitin sulfate (CS) for the treatment of female recurrent urinary tract infections 2016 bmjopen-2015-009669</h6></a>
            <small class="text-muted">
                1219 Views . <timeago class="timeago" datetime="2019-10-31 13:38:52.835202"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="intravesical-treatment-with-highly-concentrated-hyaluronic-acid-and-chondroitin-sulphate-in-patients-with-recurrent-urinary-tract-infections-results-from-a-multicentre-survey-cuaj-9-10-e721-31.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/31/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="intravesical-treatment-with-highly-concentrated-hyaluronic-acid-and-chondroitin-sulphate-in-patients-with-recurrent-urinary-tract-infections-results-from-a-multicentre-survey-cuaj-9-10-e721-31.html"><h6 class="mb-1">Intravesical treatment with highly-concentrated hyaluronic acid and chondroitin sulphate in patients with recurrent urinary tract infections- Results from a multicentre survey.cuaj-9-10-e721</h6></a>
            <small class="text-muted">
                1386 Views . <timeago class="timeago" datetime="2019-10-31 13:39:08.628954"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="ic-bps-and-glycosaminoglycans-replacement-therapy-2015-tau-04-06-638-32.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/32/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="ic-bps-and-glycosaminoglycans-replacement-therapy-2015-tau-04-06-638-32.html"><h6 class="mb-1">IC_BPS and glycosaminoglycans replacement therapy 2015 tau-04-06-638</h6></a>
            <small class="text-muted">
                1249 Views . <timeago class="timeago" datetime="2019-10-31 13:39:22.993300"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="managing-chronic-bladder-diseases-with-the-administration-of-exogenous-glycosaminoglycans-an-update-on-the-evidence-2016-urology-33.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/33/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="managing-chronic-bladder-diseases-with-the-administration-of-exogenous-glycosaminoglycans-an-update-on-the-evidence-2016-urology-33.html"><h6 class="mb-1">Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans- an update on the evidence 2016 Urology</h6></a>
            <small class="text-muted">
                1387 Views . <timeago class="timeago" datetime="2019-10-31 13:40:52.836690"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="hyaluronic-acid-and-its-composites-as-a-local-antimicrobial-antiadhesive-barrier-2017-jbjiv02p0063-34.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/34/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="hyaluronic-acid-and-its-composites-as-a-local-antimicrobial-antiadhesive-barrier-2017-jbjiv02p0063-34.html"><h6 class="mb-1">Hyaluronic Acid and Its Composites as a Local Antimicrobial-Antiadhesive Barrier 2017.jbjiv02p0063</h6></a>
            <small class="text-muted">
                1309 Views . <timeago class="timeago" datetime="2019-10-31 13:45:41.648470"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="evidence-based-criteria-for-the-pain-of-ic-bps-in-women-2008-nihms43157-35.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/35/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="evidence-based-criteria-for-the-pain-of-ic-bps-in-women-2008-nihms43157-35.html"><h6 class="mb-1">Evidence-based criteria for the pain of IC_BPS in women 2008 nihms43157</h6></a>
            <small class="text-muted">
                1299 Views . <timeago class="timeago" datetime="2019-10-31 13:45:59.326213"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="intravesical-glycosaminoglycan-replacement-with-chondroitin-2015-article-306-36.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/36/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="intravesical-glycosaminoglycan-replacement-with-chondroitin-2015-article-306-36.html"><h6 class="mb-1">Intravesical Glycosaminoglycan Replacement with Chondroitin_2015_Article_306</h6></a>
            <small class="text-muted">
                1357 Views . <timeago class="timeago" datetime="2019-10-31 13:46:19.773972"></timeago>
            </small>
        </div>
    </li>

                                    
                                </ul>
                            </div>
                        </div>
                        <div role="tabpanel" id="most_viewed" class="tab-pane  mt4">
                            <div class="card">
                                <ul class="list-unstyled card-body">
                                    
                                    
                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="sugarvedo-ruhazat-ismerteto-3.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/3/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="sugarvedo-ruhazat-ismerteto-3.html"><h6 class="mb-1">Sugárvédő ruházat ismertető</h6></a>
            <small class="text-muted">
                3283 Views . <timeago class="timeago" datetime="2018-10-20 14:31:25.547995"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="op-set-system-5.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/5/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="op-set-system-5.html"><h6 class="mb-1">OP Set System</h6></a>
            <small class="text-muted">
                3042 Views . <timeago class="timeago" datetime="2018-11-16 13:38:03.543744"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="kompresszios-polya-felhelyezese-8.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/8/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="kompresszios-polya-felhelyezese-8.html"><h6 class="mb-1">Kompressziós pólya felhelyezése</h6></a>
            <small class="text-muted">
                2845 Views . <timeago class="timeago" datetime="2018-11-16 13:39:25.884480"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="kotszer-polya-l-r-6.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/6/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="kotszer-polya-l-r-6.html"><h6 class="mb-1">Kötszer Pólya L&amp;R</h6></a>
            <small class="text-muted">
                2642 Views . <timeago class="timeago" datetime="2018-11-16 13:38:35.611223"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="nedves-sebkezeles-flyer-l-r-7.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/7/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="nedves-sebkezeles-flyer-l-r-7.html"><h6 class="mb-1">Nedves sebkezelés flyer L&amp;R</h6></a>
            <small class="text-muted">
                2437 Views . <timeago class="timeago" datetime="2018-11-16 13:38:59.835920"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="pdb-actico-ulcersys-liner-10.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/10/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="pdb-actico-ulcersys-liner-10.html"><h6 class="mb-1">PDB_Actico UlcerSys Liner</h6></a>
            <small class="text-muted">
                2323 Views . <timeago class="timeago" datetime="2018-11-16 13:39:54.728282"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="scican-statim-g4-2.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/2/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="scican-statim-g4-2.html"><h6 class="mb-1">SciCan STATIM G4</h6></a>
            <small class="text-muted">
                2320 Views . <timeago class="timeago" datetime="2018-10-20 14:10:02.671163"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="pdb-actico-ulcersys-9.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/9/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="pdb-actico-ulcersys-9.html"><h6 class="mb-1">PDB_Actico UlcerSys</h6></a>
            <small class="text-muted">
                2208 Views . <timeago class="timeago" datetime="2018-11-16 13:39:42.488113"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="urostill-hasznalati-utmutato-v1-1-12.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/12/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="urostill-hasznalati-utmutato-v1-1-12.html"><h6 class="mb-1">UroStill_hasznalati_utmutato_v1.1</h6></a>
            <small class="text-muted">
                2037 Views . <timeago class="timeago" datetime="2019-10-31 13:22:24.531510"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="koronavirus-jarvany-61.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/61/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="koronavirus-jarvany-61.html"><h6 class="mb-1">KORONAVIRUS JARVANY</h6></a>
            <small class="text-muted">
                1773 Views . <timeago class="timeago" datetime="2020-04-09 15:16:22.317496"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="scican-statim-g4-1.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/1/image_thumb.jpg"/>
        </a>
        <div class="media-body">
            <a href="scican-statim-g4-1.html"><h6 class="mb-1">SciCan Statim G4</h6></a>
            <small class="text-muted">
                1708 Views . <timeago class="timeago" datetime="2018-10-20 14:09:31.661802"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="new-aiding-device-for-self-instillation-v2-16.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/16/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="new-aiding-device-for-self-instillation-v2-16.html"><h6 class="mb-1">New_aiding_device_for_self-instillation_v2</h6></a>
            <small class="text-muted">
                1689 Views . <timeago class="timeago" datetime="2019-10-31 13:23:48.863175"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="kitpack-11.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/11/image_thumb.jpg"/>
        </a>
        <div class="media-body">
            <a href="kitpack-11.html"><h6 class="mb-1">Kitpack</h6></a>
            <small class="text-muted">
                1684 Views . <timeago class="timeago" datetime="2018-11-16 14:52:39.736537"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="icbps-szoszedet-14.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/14/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="icbps-szoszedet-14.html"><h6 class="mb-1">ICBPS_SZÓSZEDET</h6></a>
            <small class="text-muted">
                1617 Views . <timeago class="timeago" datetime="2019-10-31 13:23:06.826135"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="ic-faq-s-and-appropriate-answers-mumbai-2019-15.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/15/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="ic-faq-s-and-appropriate-answers-mumbai-2019-15.html"><h6 class="mb-1">IC - FAQ-s and appropriate answers Mumbai 2019</h6></a>
            <small class="text-muted">
                1611 Views . <timeago class="timeago" datetime="2019-10-31 13:23:19.219912"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="urostill-users-manual-v1-1-13.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/13/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="urostill-users-manual-v1-1-13.html"><h6 class="mb-1">UroStill_Users_Manual_v1.1</h6></a>
            <small class="text-muted">
                1604 Views . <timeago class="timeago" datetime="2019-10-31 13:22:47.677753"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="l-r-corporate-film-4.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/4/image_thumb.jpg"/>
        </a>
        <div class="media-body">
            <a href="l-r-corporate-film-4.html"><h6 class="mb-1">L&amp;R Corporate Film</h6></a>
            <small class="text-muted">
                1601 Views . <timeago class="timeago" datetime="2018-11-14 15:53:51.760680"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="cuaj-5-6-e136-17.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/17/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="cuaj-5-6-e136-17.html"><h6 class="mb-1">cuaj-5-6-e136</h6></a>
            <small class="text-muted">
                1557 Views . <timeago class="timeago" datetime="2019-10-31 13:27:48.254982"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="minimally-invasive-device-for-intravesical-instillation-lovasz-2019-international-journal-of-urology-18.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/18/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="minimally-invasive-device-for-intravesical-instillation-lovasz-2019-international-journal-of-urology-18.html"><h6 class="mb-1">Minimally invasive device for intravesical instillation-Lovasz-2019-International_Journal_of_Urology</h6></a>
            <small class="text-muted">
                1503 Views . <timeago class="timeago" datetime="2019-10-31 13:28:10.125299"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="ic-bps-treatment-checklist-20.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/20/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="ic-bps-treatment-checklist-20.html"><h6 class="mb-1">IC-BPS Treatment Checklist</h6></a>
            <small class="text-muted">
                1497 Views . <timeago class="timeago" datetime="2019-10-31 13:28:50.163748"></timeago>
            </small>
        </div>
    </li>

                                    
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    
                </main>
                <footer class="bg-light o_footer">
                    <div id="footer" class="oe_structure oe_structure_solo">
      <section class="s_text_block pb8 pt40">
        <div class="container">
          <div class="row" style="border-top: solid 1px #ddd; padding-top: 30px;">
            <div class="col-lg-4">
              <h5>További tartalmak</h5>
              <ul class="list-unstyled">
                <li>
                  <a href="../../blog/hirek-esemenyek-1.html" data-original-title="" title="" aria-describedby="tooltip310735">Hírek</a>
                  <br/>
                  <a href="../../adatkezelesi-tajekoztato.html">Adatkezelési tájékoztató</a>
                </li>
                <li>
                  <br/>
                </li>
              </ul>
            </div>
            <div class="col-lg-4" id="connect">
              <h5>Elérhetőségek</h5>
              <ul class="list-unstyled">
                <li>
                  <i class="fa fa-phone"></i>
                  <span data-note-id="2">+36 1 452 1700</span>
                </li>
                <li>
                  <i class="fa fa-envelope"></i>
                  <span><a href="../../cdn-cgi/l/email-protection.html" class="__cf_email__" data-cfemail="d3babdb5bc93bbb1a0fdbba6">[email&#160;protected]</a></span>
                </li>
              </ul>
              <p> </p>
            </div>
            <div class="col-lg-4">
              <h5>
                <span>HBS Medical</span>
                <small> – <a href="../../aboutus.html" data-original-title="" title="" aria-describedby="tooltip425138">Kapcsolat</a></small>
              </h5>
              <p>&nbsp;<br/></p>
            </div>
          </div>
        </div>
      </section>
    </div>
  <div class="o_footer_copyright">
            <div class="container">
                <div class="row">
                    <div class="col-lg-6 text-muted text-center text-md-left">
                        <span>Copyright &copy;</span> <span itemprop="name">HBS Medical</span>
                        
    

                    </div>
                    <div class="col-lg-6 text-right o_not_editable">
                        
    <!--<div class="o_brand_promotion text-muted">
        Az oldalt készítette:
        <a href="https://eyssen.hu/" target="_blank"><img src="../../web/image/606/eyssen_logo_blue.png" width="120"/></a>
    </div>-->

                    </div>
                </div>
            </div>
        </div>
    </footer>
            </div>
        <script data-cfasync="false" src="../../cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script id="tracking_code">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');

            ga('create', _.str.trim('UA-52898474-1'), 'auto');
            ga('send','pageview');
        </script>
    
        
            </body>
        
<!-- Mirrored from hbs.hu/slides/slide/diagnostic-criteria-classification-and-nomenclature-for-59 by HTTrack Website Copier/3.x [XR&CO'2014], Mon, 31 May 2021 15:59:13 GMT -->
</html>
    
    
